Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
37,281,723
-
Share change
-
+377,506
-
Total reported value
-
$924,868,486
-
Put/Call ratio
-
12%
-
Price per share
-
$24.79
-
Number of holders
-
95
-
Value change
-
+$10,811,295
-
Number of buys
-
47
-
Number of sells
-
35
Institutional Holders of AIMMUNE THERAPEUTICS INC - COM (AIMT) as of Q3 2017
As of 30 Sep 2017 AIMMUNE THERAPEUTICS INC - COM (AIMT) had 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 37,281,723 shares of stock of the company.
Largest 10 holders included Foresite Capital Management II, LLC, Aisling Capital LLC, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, EAGLE ASSET MANAGEMENT INC, TLP GROUP LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, and Palo Alto Investors, LLC.
This table shows 95 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.